We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+20.33%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$600M
AUM Growth
+$79.5M
Cap. Flow
+$21.8M
Cap. Flow %
3.64%
Top 10 Hldgs %
21.67%
Holding
133
New
15
Increased
59
Reduced
31
Closed
12

Top Buys

Rank Stock Value
1
MMSI icon
Merit Medical Systems
MMSI
+$6.18M
2
PRVA icon
Privia Health
PRVA
+$5.98M
3
CNMD icon
CONMED
CNMD
+$5.55M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$5.01M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$4.97M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$12.1M
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$11.6M
3
IMGN
Immunogen Inc
IMGN
+$6.67M
4
BLU
BELLUS Health Inc.
BLU
+$5.53M
5
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$5.26M

Sector Composition

Rank Sector Weight
1 Healthcare 95.97%
2 Industrials 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWAV
51
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$5.41M 0.9%
18,950
-43,600
-70% -$12.1M
MRTX
52
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$5.37M 0.89%
148,553
+20,147
+16% +$830K
BSX icon
53
Boston Scientific
BSX
$68.4B
$5.35M 0.89%
98,976
-3,000
-3% -$157K
ABBV icon
54
AbbVie
ABBV
$465B
$5.29M 0.88%
39,300
– –
ARWR icon
55
Arrowhead Research
ARWR
$12.1B
$5.13M 0.86%
+143,922
New +$4.96M
HALO icon
56
Halozyme
HALO
$9.88B
$5.03M 0.84%
139,437
+22,037
+19% +$752K
IQV icon
57
IQVIA
IQV
$40.7B
$4.97M 0.83%
22,100
+5,800
+36% +$1.16M
GKOS icon
58
Glaukos
GKOS
$9.49B
$4.91M 0.82%
+69,000
New +$3.96M
RETA
59
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$4.84M 0.81%
47,500
+22,500
+90% +$2.13M
TSVT
60
DELISTED
2seventy bio
TSVT
$4.68M 0.78%
462,485
-13,515
-3% -$143K
MDGL icon
61
Madrigal Pharmaceuticals
MDGL
$12.6B
$4.39M 0.73%
18,985
+18,485
+3,697% +$5.01M
SLRN
62
DELISTED
ACELYRIN
SLRN
$4.2M 0.7%
+201,017
New +$4.11M
OCUL icon
63
Ocular Therapeutix
OCUL
$1.83B
$4.14M 0.69%
+802,680
New +$4.77M
NTLA icon
64
Intellia Therapeutics
NTLA
$1.51B
$4.11M 0.69%
100,832
+98,352
+3,966% +$3.99M
BIIB icon
65
Biogen
BIIB
$30.9B
$4.01M 0.67%
14,066
+1,064
+8% +$317K
CYTK icon
66
Cytokinetics
CYTK
$10.6B
$3.82M 0.64%
117,083
+33,233
+40% +$1.23M
RCKT icon
67
Rocket Pharmaceuticals
RCKT
$343M
$3.79M 0.63%
190,790
– –
TMO icon
68
Thermo Fisher Scientific
TMO
$214B
$3.74M 0.62%
7,165
-800
-10% -$432K
PODD icon
69
Insulet
PODD
$11.8B
$3.6M 0.6%
+12,500
New +$3.8M
MDT icon
70
Medtronic
MDT
$112B
$3.53M 0.59%
40,051
– –
EW icon
71
Edwards Lifesciences
EW
$49.4B
$3.37M 0.56%
35,700
+3,800
+12% +$330K
BMY icon
72
Bristol-Myers Squibb
BMY
$129B
$3.2M 0.53%
50,000
– –
IRTC icon
73
iRhythm Holdings
IRTC
$4.02B
$3.13M 0.52%
30,000
-29,136
-49% -$3.5M
VRTX icon
74
Vertex Pharmaceuticals
VRTX
$123B
$2.87M 0.48%
8,164
+1,545
+23% +$521K
EYPT icon
75
EyePoint Inc
EYPT
$999M
$2.71M 0.45%
+311,277
New +$1.9M
1 2
3
4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Sectoral Asset Management held 133 positions worth $600M, up 15% from $520M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Sectoral Asset Management deployed $21.8M of net new capital in Q2 2023, opening 15 new positions and adding to 59 existing holdings. Its largest new stake was Merit Medical Systems: 76,000 shares worth $6.36M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Shockwave Medical, Inc. Common Stock, an estimated $12.1M trimmed.

  • Sectoral Asset Management's largest Q2 2023 buy was Merit Medical Systems: 76,000 shares worth $6.36M.
  • Sectoral Asset Management added most to Privia Health in Q2 2023, an estimated $5.98M increase.
  • Sectoral Asset Management's biggest Q2 2023 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $12.1M.
  • Sectoral Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $11.6M.
  • Sectoral Asset Management's ten largest holdings make up 22% of its $600M portfolio in Q2 2023.
  • Sectoral Asset Management opened 15 new positions and closed 12 in Q2 2023.
  • Sectoral Asset Management's portfolio value rose 15% quarter-over-quarter to $600M.

Based on Sectoral Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.